Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Calmodulin-regulated serine/threonine kinases (CaM kinases) play crucial roles in Ca2+-dependent signaling transduction pathways in eukaryotes. Despite having a similar overall molecular architecture of catalytic and regulatory domains, CaM kinases employ different binding modes for Ca2+/CaM recruitment which is required for their activation. Here we present a residual dipolar coupling (RDC)-based NMR approach to characterizing the molecular recognition of CaM with five different CaM kinases. Our analyses indicate that CaM kinase I and likely IV use the same CaM binding mode as myosin light chain kinase (1-14 motif), distinct from those of CaM kinase II (1-10 motif) and CaM kinase kinase (1-16- motif). This NMR approach provides an efficient experimental guide for homology modeling and structural characterization of CaM-target complexes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/bi0264162 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ca/Calmodulin-Dependent Protein Kinase II (CaMKII)-Targeted Drug Discovery: Challenges and Strategies.
Ageing Res Rev
September 2025
Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, 110122, China; Laboratory of Naturel Medicine for drug discovery, School of Pharmacy, China Medical University, Shenyang, 110122, China. Electronic address:
Calcium (Ca)/calmodulin (CaM)-dependent protein kinase II (CaMKII) is an emerging drug target for age-related diseases. It is a multifunctional kinase with complex activation modes, numerous isoforms, broad tissue distribution, and a dual role in health and disease. In particular, its isoforms share a high degree of conservation within the catalytic and regulatory domains, with only minor differences confined to the linker region.
View Article and Find Full Text PDFThe Critical Role of the C-terminal Lobe of Calmodulin in Activating Eukaryotic Elongation Factor 2 Kinase.
J Biol Chem
August 2025
Division of Chemical Biology and Medicinal Chemistry, The University of Texas, Austin, TX, 78712; Interdisciplinary Life Sciences Graduate Program, The University of Texas, Austin, TX, 78712. Electronic address:
Eukaryotic elongation factor-2 kinase (eEF-2K), a member of the α-kinase family, modulates translational rates by phosphorylating eEF-2, a GTPase that facilitates the translocation of the nascent chain on the ribosome during the elongation phase of protein synthesis. eEF-2K is regulated by diverse cellular cues, many of which sensitize it to the Ca-effector protein calmodulin (CaM). CaM, which binds and allosterically activates eEF-2K in the presence of Ca, contains two structural "lobes," each with a pair of Ca-binding EF-hands.
View Article and Find Full Text PDFTauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates.
Biomolecules
August 2025
Department of Biology, University of Toronto Mississauga, Mississauga, ON L5L 1C6, Canada.
Tauopathies are a diverse group of neurodegenerative diseases characterized by the presence of Tau inclusions in neurons and glia. Rather than the classic steps in the transformation of Tau into neurofibrillary tangles, as first studied in Alzheimer's disease, studies on tauopathies reveal the presence of diverse Tau aggregates that appear to be disease-specific. Regardless, the phosphorylation and hyperphosphorylation of Tau, involving various kinases and phosphatases, appear to be central to all tauopathies.
View Article and Find Full Text PDFA high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells.
Nat Commun
August 2025
Department of Pathology, University of Cambridge, Cambridge, UK.
DNA replication stress is a hallmark of cancer that is exploited by chemotherapies. Current assays for replication stress have low throughput and poor resolution whilst being unable to map the movement of replication forks genome-wide. We present a new method that uses nanopore sequencing and artificial intelligence to map forks and measure their rates of movement and stalling in melanoma and colon cancer cells treated with chemotherapies.
View Article and Find Full Text PDFEnhancing oral bioavailability of pazopanib via co-amorphous system: Formulation, characterization, pharmacokinetics and toxicity evaluation.
Colloids Surf B Biointerfaces
December 2025
Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, (NIPER), Hyderabad, Telangana 500037, India. Electronic address:
Pazopanib (PZ) is an oral tyrosine kinase inhibitor and the first line of treatment for patients with renal cell carcinoma. The low solubility, poor bioavailability, and high hepatotoxicity of PZ hamper its potential use. The present research aims to improve the bioavailability and reduce hepatotoxicity of PZ by fabricating a co-amorphous system (CAM) using naringin (NGN) to form Pazopanib Naringin Co-amorphous system (PZ-NGN-CAM).
View Article and Find Full Text PDF